Poly (ADP-ribose) polymerase 1 promotes HuR/ELAVL1 cytoplasmic localization and inflammatory gene expression by regulating p38 MAPK activity
-
Published:2024-06-09
Issue:1
Volume:81
Page:
-
ISSN:1420-682X
-
Container-title:Cellular and Molecular Life Sciences
-
language:en
-
Short-container-title:Cell. Mol. Life Sci.
Author:
Fu Xingyue, Zhang Jiaqi, Sun Keke, Zhang Meiqi, Wang Shuyan, Yuan Meng, Liu Wenguang, Zeng Xianlu, Ba Xueqing, Ke YueshuangORCID
Abstract
AbstractPost-transcriptional regulation of cytokine/chemokine mRNA turnover is critical for immune processes and contributes to the mammalian cellular response to diverse inflammatory stimuli. The ubiquitous RNA-binding protein human antigen R (HuR) is an integral regulator of inflammation-associated mRNA fate. HuR function is regulated by various post-translational modifications that alter its subcellular localization and ability to stabilize target mRNAs. Both poly (ADP-ribose) polymerase 1 (PARP1) and p38 mitogen-activated protein kinases (MAPKs) have been reported to regulate the biological function of HuR, but their specific regulatory and crosstalk mechanisms remain unclear. In this study, we show that PARP1 acts via p38 to synergistically promote cytoplasmic accumulation of HuR and stabilization of inflammation-associated mRNAs in cells under inflammatory conditions. Specifically, p38 binds to auto-poly ADP-ribosylated (PARylated) PARP1 resulting in the covalent PARylation of p38 by PARP1, thereby promoting the retention and activity of p38 in the nucleus. In addition, PARylation of HuR facilitates the phosphorylation of HuR at the serine 197 site mediated by p38, which then increases the translocation of HuR to the cytoplasm, ultimately stabilizing the inflammation-associated mRNA expression at the post-transcriptional level.
Funder
Natural Science Foundation of Jilin Province National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Grammatikakis I, Abdelmohsen K, Gorospe M (2017) Posttranslational control of HuR function, Wiley interdisciplinary reviews. RNA 8(1) 2. Schultz CW, Preet R, Dhir T, Dixon DA, Brody JR (2020) Understanding and targeting the disease-related RNA binding protein human antigen R (HuR). Wiley Interdiscip Rev RNA 11(3):e1581 3. Majumder M, Chakraborty P, Mohan S, Mehrotra S, Palanisamy V HuR (2022) As a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliver Rev 188 4. Wu X Q, Xu L (2022) The RNA-binding protein HuR in human cancer: a friend or foe. Adv Drug Deliver Rev 184 5. Palomo-Irigoyen M, Perez-Andres E, Iruarrizaga-Lejarreta M, Barreira-Manrique A, Tamayo-Caro M, Vila-Vecilla L, Moreno-Cugnon L, Beitia N, Medrano D, Fernandez-Ramos D, Lozano JJ, Okawa S, Lavin JL, Martin-Martin N, Sutherland JD, de Juan VG, Gonzalez-Lopez M, Macias-Camara N, Mosen-Ansorena D, Laraba L, Hanemann CO, Ercolano E, Parkinson DB, Schultz CW, Arauzo-Bravo MJ, Ascension AM, Gerovska D, Iribar H, Izeta A, Pytel P, Krastel P, Provenzani A, Seneci P, Carrasco RD, Del Sol A, Martinez-Chantar ML, Barrio R, Serra E, Lazaro C, Flanagan AM, Gorospe M, Ratner N, Aransay AM, Carracedo A, Varela-Rey M, Woodhoo A (2020) HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis. J Clin Investig 130(7):3848–3864
|
|